71 related articles for article (PubMed ID: 17369879)
21. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
[TBL] [Abstract][Full Text] [Related]
22. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
[TBL] [Abstract][Full Text] [Related]
24. Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells.
Peng XC; Wang M; Chen XX; Liu J; Xiao GH; Liao HL
Mol Cell Biochem; 2014 Oct; 395(1-2):265-72. PubMed ID: 24997628
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model.
Verheul HM; Hammers H; van Erp K; Wei Y; Sanni T; Salumbides B; Qian DZ; Yancopoulos GD; Pili R
Clin Cancer Res; 2007 Jul; 13(14):4201-8. PubMed ID: 17634549
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
[TBL] [Abstract][Full Text] [Related]
27. Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.
Kohlmeyer J; Cron M; Landsberg J; Bald T; Renn M; Mikus S; Bondong S; Wikasari D; Gaffal E; Hartmann G; Tüting T
Cancer Res; 2009 Aug; 69(15):6265-74. PubMed ID: 19622767
[TBL] [Abstract][Full Text] [Related]
28. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
[TBL] [Abstract][Full Text] [Related]
29. The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients.
Mans S; Banz Y; Mueller BU; Pabst T
Blood; 2012 Sep; 120(13):2690-9. PubMed ID: 22915645
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
[TBL] [Abstract][Full Text] [Related]
31. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
[TBL] [Abstract][Full Text] [Related]
32. The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses.
Lange-Asschenfeldt B; Velasco P; Streit M; Hawighorst T; Pike SE; Tosato G; Detmar M
J Invest Dermatol; 2001 Nov; 117(5):1036-41. PubMed ID: 11710910
[TBL] [Abstract][Full Text] [Related]
33. Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model.
Mittal S; Tsume Y; Landowski CP; Lee KD; Hilfinger JM; Amidon GL
Eur J Pharm Biopharm; 2007 Nov; 67(3):752-8. PubMed ID: 17560100
[TBL] [Abstract][Full Text] [Related]
34. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
35. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
36. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
Marimpietri D; Brignole C; Nico B; Pastorino F; Pezzolo A; Piccardi F; Cilli M; Di Paolo D; Pagnan G; Longo L; Perri P; Ribatti D; Ponzoni M
Clin Cancer Res; 2007 Jul; 13(13):3977-88. PubMed ID: 17606732
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
38. Tumor angiogenesis in melanoma.
Marneros AG
Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
[TBL] [Abstract][Full Text] [Related]
39. Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.
Zou Y; Chen Y; Jiang Y; Gao J; Gu J
Cancer Res; 2007 Aug; 67(15):7295-300. PubMed ID: 17671198
[TBL] [Abstract][Full Text] [Related]
40. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth.
Pike SE; Yao L; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
J Exp Med; 1998 Dec; 188(12):2349-56. PubMed ID: 9858521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
